PortfoliosLab logoPortfoliosLab logo
VXRT vs. AMLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VXRT vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vaxart, Inc. (VXRT) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VXRT achieves a 55.89% return, which is significantly lower than AMLX's 68.13% return.


VXRT

1D
2.46%
1M
-15.63%
6M
-6.86%
YTD
55.89%
1Y
51.77%
3Y*
-11.52%
5Y*
-40.42%
10Y*
ALL TIME*
-27.88%

AMLX

1D
-2.12%
1M
11.17%
6M
42.13%
YTD
68.13%
1Y
163.25%
3Y*
-4.58%
5Y*
10Y*
ALL TIME*
-0.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$41.59M$31.68M$25.94M
$154.47K$165.76K$219.97K

VXRT vs. AMLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
VXRT
Vaxart, Inc.
55.89%-47.68%15.59%-40.39%-84.48%
AMLX
Amylyx Pharmaceuticals, Inc.
68.13%219.58%-74.32%-60.16%75.95%

Correlation

The correlation between VXRT and AMLX is 0.12, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.12

Correlation (3Y)
Balances recent behavior with more history.

0.19

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2022

0.22

Fundamentals

Market Cap

VXRT:

$130.70M

AMLX:

$2.26B

EPS

VXRT:

$0.16

AMLX:

-$1.51

PB Ratio

VXRT:

1.39

AMLX:

8.22

Total Revenue (TTM)

VXRT:

$255.61M

AMLX:

$0.00

Gross Profit (TTM)

VXRT:

$193.63M

AMLX:

-$20.10M

EBITDA (TTM)

VXRT:

$45.63M

AMLX:

-$150.30M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VXRT vs. AMLX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

VXRT
VXRT Risk / Return Rank: 6767
Overall Rank
VXRT Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
VXRT Sortino Ratio Rank: 6969
Sortino Ratio Rank
VXRT Omega Ratio Rank: 7070
Omega Ratio Rank
VXRT Calmar Ratio Rank: 6767
Calmar Ratio Rank
VXRT Martin Ratio Rank: 6868
Martin Ratio Rank

AMLX
AMLX Risk / Return Rank: 9393
Overall Rank
AMLX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9393
Sortino Ratio Rank
AMLX Omega Ratio Rank: 8989
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9595
Calmar Ratio Rank
AMLX Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

VXRT vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vaxart, Inc. (VXRT) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VXRTAMLXDifference
Sharpe ratioReturn per unit of total volatility

-1.99

Sortino ratioReturn per unit of downside risk

-1.61

Omega ratioGain probability vs. loss probability

1.19

1.35

-0.16

Calmar ratioReturn relative to maximum drawdown

1.06

5.03

-3.97

Martin ratioReturn relative to average drawdown

2.52

10.76

-8.24

VXRT vs. AMLX - Sharpe Ratio Comparison

The current VXRT Sharpe Ratio is 0.53, which is lower than the AMLX Sharpe Ratio of 2.51. The chart below compares the historical Sharpe Ratios of VXRT and AMLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VXRT vs. AMLX - Drawdown Comparison

The maximum VXRT drawdown since its inception was -98.71%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for VXRT and AMLX.


Loading charts...

Drawdown Indicators


VXRTAMLXDifference

Max Drawdown

Largest peak-to-trough decline

-98.71%

-96.04%

-2.67%

Max Drawdown (1Y)

Largest decline over 1 year

-43.74%

-30.61%

-13.13%

Max Drawdown (3Y)

Largest decline over 3 years

-78.72%

-92.82%

+14.10%

Max Drawdown (5Y)

Largest decline over 5 years

-96.94%

Current Drawdown

Current decline from peak

-97.69%

-50.38%

-47.31%

Average Drawdown

Average peak-to-trough decline

-83.17%

-59.30%

-23.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.26%

14.27%

+3.99%

Volatility

VXRT vs. AMLX - Volatility Comparison

Vaxart, Inc. (VXRT) has a higher volatility of 22.10% compared to Amylyx Pharmaceuticals, Inc. (AMLX) at 15.49%. This indicates that VXRT's price experiences larger fluctuations and is considered to be riskier than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VXRTAMLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.10%

15.49%

+6.61%

Volatility (6M)

Calculated over the trailing 6-month period

50.47%

39.64%

+10.83%

Volatility (1Y)

Calculated over the trailing 1-year period

87.77%

61.22%

+26.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.48%

90.71%

+1.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

127.94%

90.71%

+37.23%

Dividends

VXRT vs. AMLX - Dividend Comparison

Neither VXRT nor AMLX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VXRT vs. AMLX - Financials Comparison

This section allows you to compare key financial metrics between Vaxart, Inc. and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


VXRT and AMLX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VXRT has higher volatility (22.10%) compared to AMLX (15.49%). In terms of maximum drawdown, VXRT dropped -98.71% vs AMLX's -96.04%.

AMLX currently has the higher Sharpe Ratio (2.51 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VXRT and AMLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer